Literature DB >> 7506033

Interaction of the natural anti-Gal antibody with alpha-galactosyl epitopes: a major obstacle for xenotransplantation in humans.

U Galili1.   

Abstract

Cells of nonprimate mammals express an abundance of the carbohydrate structure Gal alpha 1-3 Gal beta 1-4 GlcNac-R (termed the alpha-galactosyl epitope). The natural anti-Gal antibody, which interacts specifically with alpha-galactosyl epitopes, is present in high concentrations in all humans. Here, Uri Galili argues that the interaction between anti-Gal in the serum and alpha-galactosyl epitopes on cells of nonprimate grafts may act as an immunological barrier which prevents xenotransplantation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7506033     DOI: 10.1016/0167-5699(93)90261-i

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  96 in total

Review 1.  Tolerance by transplantation: how much is enough, how much is too much?

Authors:  J L Platt
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

2.  B cell clonal elimination induced by membrane-bound self-antigen may require repeated antigen encounter or cell competition.

Authors:  J Lang; D Nemazee
Journal:  Eur J Immunol       Date:  2000-02       Impact factor: 5.532

3.  Immunochemical properties of anti-Gal alpha 1-3Gal antibodies after sensitization with xenogeneic tissues.

Authors:  P B Yu; W Parker; M L Everett; I J Fox; J L Platt
Journal:  J Clin Immunol       Date:  1999-03       Impact factor: 8.317

4.  Profiling terminal N-acetyllactosamines of glycans on mammalian cells by an immuno-enzymatic assay.

Authors:  Haruko Ogawa; Uri Galili
Journal:  Glycoconj J       Date:  2006-11-18       Impact factor: 2.916

Review 5.  Immune response to biologic scaffold materials.

Authors:  Stephen F Badylak; Thomas W Gilbert
Journal:  Semin Immunol       Date:  2008-02-20       Impact factor: 11.130

Review 6.  Immune problems in central nervous system cell therapy.

Authors:  Roger A Barker; Håkan Widner
Journal:  NeuroRx       Date:  2004-10

Review 7.  Clinically feasible approaches to potentiating cancer cell-based immunotherapies.

Authors:  V I Seledtsov; A G Goncharov; G V Seledtsova
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

8.  Increased levels of anti-non-Gal IgG following pig-to-baboon bone marrow transplantation correlate with failure of engraftment.

Authors:  Fan Liang; Isaac Wamala; Joseph Scalea; Aseda Tena; Taylor Cormack; Shannon Pratts; Raimon Duran-Struuck; Nahel Elias; Martin Hertl; Christene A Huang; David H Sachs
Journal:  Xenotransplantation       Date:  2013-10-29       Impact factor: 3.907

9.  Identification of the V genes encoding xenoantibodies in non-immunosuppressed rhesus monkeys.

Authors:  Annette Kleihauer; Clare R Gregory; Dominic C Borie; Andrew E Kyles; Irina Shulkin; Insiyyah Patanwala; Joanne Zahorsky-Reeves; Vaughn A Starnes; Yoko Mullen; Ivan T Todorov; Mary Kearns-Jonker
Journal:  Immunology       Date:  2005-09       Impact factor: 7.397

10.  Immunoglobulin prevents complement-mediated hyperacute rejection in swine-to-primate xenotransplantation.

Authors:  J C Magee; B H Collins; R C Harland; B J Lindman; R R Bollinger; M M Frank; J L Platt
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.